|
|
Volumn 104, Issue 24, 2012, Pages 1853-1855
|
|
DCIS test helps filter at-risk patients.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BREAST TUMOR;
CLINICAL TRIAL (TOPIC);
EARLY DIAGNOSIS;
FEMALE;
GENETICS;
HUMAN;
INTRADUCTAL CARCINOMA;
MASS SCREENING;
METHODOLOGY;
NOTE;
PAGET NIPPLE DISEASE;
PATIENT ADVOCACY;
PREDICTIVE VALUE;
REGISTER;
RISK ASSESSMENT;
RISK FACTOR;
TUMOR RECURRENCE;
UNITED KINGDOM;
UNITED STATES;
UNNECESSARY PROCEDURE;
VALIDATION STUDY;
BREAST NEOPLASMS;
CARCINOMA, DUCTAL, BREAST;
CARCINOMA, INTRADUCTAL, NONINFILTRATING;
CLINICAL TRIALS AS TOPIC;
EARLY DETECTION OF CANCER;
FEMALE;
GREAT BRITAIN;
HUMANS;
MASS SCREENING;
NEOPLASM RECURRENCE, LOCAL;
PATIENT ADVOCACY;
PREDICTIVE VALUE OF TESTS;
REGISTRIES;
RISK ASSESSMENT;
RISK FACTORS;
UNITED STATES;
UNNECESSARY PROCEDURES;
VALIDATION STUDIES AS TOPIC;
|
|
EID: 84873497419
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djs515 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
